Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes Than with Either Monotherapy in Patients with Early Rheumatoid Arthritis: 8-Year Results of An Open-Label Extension of a Phase 3 Trial

被引：0

作者：

Breedveld, Ferdinand C. ^{[1
]}

Keystone, Edward ^{[2
]}

van der Heijde, Desiree ^{[1
]}

Landewe, Robert ^{[3
]}

Smolen, Josef ^{[4
,5
]}

Guerette, Benoit ^{[6
]}

McIlraith, Melissa ^{[6
]}

Kupper, Hartmut ^{[7
]}

Liu, Shufang ^{[8
]}

Wolfe, Benjamin ^{[8
]}

Kavanaugh, Arthur ^{[9
]}

机构：

[1] Leiden Univ, Med Ctr, Leiden, Netherlands

[2] Univ Toronto, Toronto, ON, Canada

[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[4] Med Univ Vienna, Vienna, Austria

[5] Hietzing Hosp, Vienna, Austria

[6] Abbott, Rungis, France

[7] Abbott GmbH & Co KG, Ludwigshafen, Germany

[8] Abbott, Abbott Pk, IL USA

[9] Univ Calif San Diego, San Diego, CA 92103 USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1231

引用

页码：S481 / S481

页数：1

共 50 条

[21] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 24-Week Randomized Controlled Trial and Open-Label Extension Study
Smolen, Josef
Van Vollenhoven, Ronald
Kavanaugh, Arthur
Strand, Vibeke
Vencovsky, Jiri
Schiff, Michael
Landewe, Robert
Haraoui, Boulos
Walker, Susan
van der Heijde, Desiree
JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1506 - 1507
[22] LONG-TERM BENEFITS OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY ON HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
Strand, V.
Purcaru, O.
van Vollenhoven, R.
Choy, E.
Fleischmann, R.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 441 - 442
[23] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study
Smolen, Josef S.
van Vollenhoven, Ronald
Kavanaugh, Arthur
Strand, Vibeke
Vencovsky, Jiri
Schiff, Michael H.
Landewe, Robert
Haraoui, Boulos
Walker, Susan
van der Heijde, Desiree
ARTHRITIS AND RHEUMATISM, 2013, 65 : S988 - S989
[24] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
Keystone, Edward
Landewe, Robert
van Vollenhoven, Ronald
Combe, Bernard
Strand, Vibeke
Mease, Philip J.
Shaughnessy, Laura
VanLunen, Brenda
van der Heijde, Desiree
ARTHRITIS AND RHEUMATISM, 2013, 65 : S596 - S597
[25] Patient-Reported Outcomes of Long-Term Upadacitinib Use in Patients with Rheumatoid Arthritis: Interim Analysis Results of a Phase 2, Open-Label Extension Study
Strand, Vibeke
Tundia, Namita
Friedman, Alan
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[26] Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
Fleischmann, Roy M.
van Vollenhoven, Ronald F.
Vencovsky, Jiri
Alten, Rieke
Davies, Owen
Stach, Christian
de Longueville, Marc
Van Lunen, Brenda
Choy, Ernest
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S565 - S566
[27] Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
Zouboulis, Christos C.
Okun, Martin M.
Prens, Errol P.
Gniadecki, Robert
Foley, Peter A.
Lynde, Charles
Weisman, Jamie
Gu, Yihua
Williams, David A.
Jemec, Gregor B. E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 60 - +
[28] Long-Term Efficacy of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled POS: Results from a Phase III Open-Label Extension Trial
Chung, Steve
Faught, Raymond Edward
Husain, Aatif
Isojarvi, Jouko
Doty, Pamela
NEUROLOGY, 2011, 76 (09) : A376 - A376
[29] LONG-TERM SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH UNCONTROLLED POS: RESULTS FROM A PHASE III OPEN-LABEL EXTENSION TRIAL
Husain, A.
Faught, E.
Chung, S.
Isojarvi, J.
McShea, C.
Doty, P.
EPILEPSIA, 2011, 52 : 155 - 155
[30] Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients
Josef S. Smolen
Ronald van Vollenhoven
Arthur Kavanaugh
Vibeke Strand
Jiri Vencovsky
Michael Schiff
Robert Landewé
Boulos Haraoui
Catherine Arendt
Irina Mountian
David Carter
Désirée van der Heijde
Arthritis Research & Therapy, 17

← 1 2 3 4 5 →